Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID Reference, 4th edition, 372 pages + the daily Top 10

Head and Neck Cancer

Free Subscription 20.07.2020 2 Ann Surg 8 Anticancer Res 1 BMC Cancer 3 Br J Cancer 4 Br J Oral Maxillofac Surg 3 Cancer 4 Clin Cancer Res 1 Clin Nucl Med 6 Head Neck 1 Histopathology 3 HNO 1 Hum Pathol 1 Int J Cancer 1 Int J Pediatr Otorhinolaryngol 1 Laryngoscope 9 Oral Oncol 5 Otolaryngol Head Neck Surg 4 PLoS One 2 Proc Natl Acad Sci U S A 5 Radiother Oncol 1 Surgery

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Ann Surg

1. YOSHIDA N, Baba H
   Response to the Letter to the Editor for "Clinical Importance of Mean Corpuscular Volume as a Prognostic Marker After Esophagectomy for Esophageal Cancer: A Retrospective Study".
   Ann Surg. 2020 Jul 9. doi: 10.1097/SLA.0000000000004128.
   PubMed        
   
   
2. LENSCHOW C, Schragle S, Kircher S, Lorenz K, et al
   Clinical Presentation, Treatment, and Outcome of Parathyroid Carcinoma: Results of the NEKAR Retrospective International Multicenter Study.
   Ann Surg. 2020 Jul 7. doi: 10.1097/SLA.0000000000004144.
   PubMed         Abstract available
   
   

   
   Anticancer Res

3. TUNG KL, Wu YT, Liu C, Lin SC, et al
   EBV Rta-induced IL-6 Promotes Migration of Bystander Tumor Cells Through IL-6R/JAK/STAT3 Pathway In Vitro.
   Anticancer Res. 2020;40:3255-3264.
   PubMed         Abstract available
   
   
4. SAMHOURI L, Kriz J, Elsayad K, Channaoui M, et al
   The Role of Radiotherapy for Patients With Thyroid Cancer in the Modern Era.
   Anticancer Res. 2020;40:3379-3386.
   PubMed         Abstract available
   
   
5. IIJIMA Y, Bandow K, Amano S, Sano M, et al
   Protection of Bortezomib-induced Neurotoxicity by Antioxidants.
   Anticancer Res. 2020;40:3685-3696.
   PubMed         Abstract available
   
   
6. LI CH, Shih LC, Hsu CL, Lee HT, et al
   The Contribution of Interleukin-12A Genotypes to Oral Cancer Risk in Taiwanese.
   Anticancer Res. 2020;40:3707-3712.
   PubMed         Abstract available
   
   
7. CHRYSOVERGIS A, Papanikolaou V, Mastronikolis N, Tsiambas E, et al
   Chromosome 17 In Situ Hybridization Grid-based Analysis in Oral Squamous Cell Carcinoma.
   Anticancer Res. 2020;40:3759-3764.
   PubMed         Abstract available
   
   
8. KOMATSU N, Komatsu M, Ohashi R, Horii A, et al
   Photosensitizer With Illumination Enhances In Vivo Antitumor Effect of Anti-ROBO1 Immunotoxin on Maxillary Sinus Squamous Cell Carcinoma.
   Anticancer Res. 2020;40:3793-3799.
   PubMed         Abstract available
   
   
9. JEONG JY, Park TI, Ahn D
   Comprehensive Analysis and Clinical Implication of PD-L1 Expression Considering HPV Status in Oropharyngeal Squamous Cell Carcinoma.
   Anticancer Res. 2020;40:4001-4010.
   PubMed         Abstract available
   
   
10. KUBO K, Murakami Y, Imano N, Takeuchi Y, et al
    A Single Institution's Experience of Definitive Radiotherapy Using Volumetric-modulated Arc Therapy for Hypopharyngeal Cancers.
    Anticancer Res. 2020;40:4183-4190.
    PubMed         Abstract available
    
    

    
    BMC Cancer

11. JIANG X, Huang Z, Sun X, Zheng X, et al
    CCL18-NIR1 promotes oral cancer cell growth and metastasis by activating the JAK2/STAT3 signaling pathway.
    BMC Cancer. 2020;20:632.
    PubMed         Abstract available
    
    

    
    Br J Cancer

12. HUTCHISON I, Hackshaw A
    Reply to Comment(s) on "Nationwide randomised trial evaluating elective neck dissection for early stage oral cancer (SEND study) with meta-analysis and concurrent real-world cohort".
    Br J Cancer. 2020 Jul 16. pii: 10.1038/s41416-020-0983.
    PubMed        
    
    
13. DHAR H, Vaish R, D'Cruz AK
    Comment on "Nationwide randomised trial evaluating elective neck dissection for early-stage oral cancer (SEND study) with meta-analysis and concurrent real-world cohort."
    Br J Cancer. 2020 Jul 16. pii: 10.1038/s41416-020-0981.
    PubMed        
    
    
14. SINGH A, Subash A, Sinha P
    Comment on "Nationwide randomised trial evaluating elective neck dissection for early stage oral cancer (SEND study) with meta-analysis and concurrent real-world cohort".
    Br J Cancer. 2020 Jul 16. pii: 10.1038/s41416-020-0982.
    PubMed        
    
    

    
    Br J Oral Maxillofac Surg

15. MIDGLEY AW, Levy AR, Price R, Cunha FA, et al
    Should survivors of head and neck cancer be considered a distinct special population within the context of exercise prescription?
    Br J Oral Maxillofac Surg. 2020 Jul 2. pii: S0266-4356(20)30125.
    PubMed        
    
    
16. DAVUDOV MM, Harirchi I, Arabkheradmand A, Garajei A, et al
    Quality of life in patients with oral cancer treated by different reconstruction methods as measured by the EORTC QLQ-H&N43.
    Br J Oral Maxillofac Surg. 2020 Jul 6. pii: S0266-4356(20)30302.
    PubMed         Abstract available
    
    
17. BRODERICK D MR, Lowe D, Kanatas A, N Rogers S, et al
    How much of a problem is too much saliva for patients following head and neck cancer.
    Br J Oral Maxillofac Surg. 2020 Jul 7. pii: S0266-4356(20)30257.
    PubMed         Abstract available
    
    
18. DAHILL A, Al-Nakisbandi H, Cunningham KB, Humphris GM, et al
    Loneliness and quality of life after head and neck cancer.
    Br J Oral Maxillofac Surg. 2020 Jul 11. pii: S0266-4356(20)30195.
    PubMed         Abstract available
    
    

    
    Cancer

19. SAITO Y, Hayashi R, Iida Y, Mizumachi T, et al
    Optimization of therapeutic strategy for p16-positive oropharyngeal squamous cell carcinoma: Multi-institutional observational study based on the national head and neck cancer registry of Japan.
    Cancer. 2020 Jul 10. doi: 10.1002/cncr.33062.
    PubMed         Abstract available
    
    
20. KANG JJ, Wong RJ, Sherman EJ, Rybkin A, et al
    The 3 B's of cancer care amid the COVID-19 pandemic crisis: "Be safe, be smart, be kind"-A multidisciplinary approach increasing the use of radiation and embracing telemedicine for head and neck cancer.
    Cancer. 2020 Jul 8. doi: 10.1002/cncr.33031.
    PubMed         Abstract available
    
    
21. SCHUTTE HW, van den Broek GB, Steens SCA, Hermens RPMG, et al
    Impact of optimizing diagnostic workup and reducing the time to treatment in head and neck cancer.
    Cancer. 2020 Jul 7. doi: 10.1002/cncr.33037.
    PubMed         Abstract available
    
    

    
    Clin Cancer Res

22. LANDA I, Pozdeyev N, Korch C, Marlow LA, et al
    Comprehensive genetic characterization of human thyroid cancer cell lines: a validated panel for preclinical studies.
    Clin Cancer Res. 2019 Feb 8. pii: 1078-0432.CCR-18-2953.
    PubMed         Abstract available
    
    
23. HARRINGTON KJ, Kong A, Mach N, Chesney J, et al
    Talimogene Laherparepvec and Pembrolizumab in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (MASTERKEY-232): A Multicenter, Phase 1b Study.
    Clin Cancer Res. 2020 Jul 15. pii: 1078-0432.CCR-20-1170.
    PubMed         Abstract available
    
    
24. UPPALURI R, Campbell KM, Egloff AM, Zolkind P, et al
    Neoadjuvant and Adjuvant Pembrolizumab in Resectable Locally Advanced, Human Papillomavirus-Unrelated Head and Neck Cancer: A Multicenter, Phase 2 Trial.
    Clin Cancer Res. 2020 Jul 14. pii: 1078-0432.CCR-20-1695.
    PubMed         Abstract available
    
    
25. WANG S, Lin Y, Xiong X, Wang L, et al
    Low-dose metformin reprograms the tumor immune microenvironment in human esophageal cancer: Results of a phase II clinical trial.
    Clin Cancer Res. 2020 Jul 9. pii: 1078-0432.CCR-20-0113.
    PubMed         Abstract available
    
    

    
    Clin Nucl Med

26. KREBS S, Petkovska I, Ho AL, Ulaner GA, et al
    Laboratory-Proven Asymptomatic SARS-CoV-2 (COVID-19) Infection on 18F-FDG PET/CT.
    Clin Nucl Med. 2020 May 19. doi: 10.1097/RLU.0000000000003141.
    PubMed         Abstract available
    
    

    
    Head Neck

27. FARQUHAR DR, Lenze NR, Masood MM, Divaris K, et al
    Access to preventive care services and stage at diagnosis in head and neck cancer.
    Head Neck. 2020 Jul 3. doi: 10.1002/hed.26326.
    PubMed         Abstract available
    
    
28. UEKI Y, Takahashi T, Ota H, Shodo R, et al
    Role of programmed death-ligand 1 in predicting the treatment outcome of salvage chemotherapy after nivolumab in recurrent/metastatic head and neck squamous cell carcinoma.
    Head Neck. 2020 Jul 16. doi: 10.1002/hed.26374.
    PubMed         Abstract available
    
    
29. DAGAN O, Moore A, Nachlon Y, Alkan U, et al
    Induction chemotherapy for locally advanced laryngeal and hypopharyngeal cancer: Single institution experience.
    Head Neck. 2020 Jul 16. doi: 10.1002/hed.26353.
    PubMed         Abstract available
    
    
30. CAPUTO MP, Shabani S, Mhaskar R, McMullen C, et al
    Diabetes mellitus in major head and neck cancer surgery: Systematic review and meta-analysis.
    Head Neck. 2020 Jul 11. doi: 10.1002/hed.26349.
    PubMed         Abstract available
    
    
31. LE ROUX MK, Graillon N, Guyot L, Taieb D, et al
    Salivary side effects after radioiodine treatment for differentiated papillary thyroid carcinoma: Long-term study.
    Head Neck. 2020 Jul 11. doi: 10.1002/hed.26359.
    PubMed         Abstract available
    
    
32. MUSORO JZ, Coens C, Singer S, Tribius S, et al
    Minimally important differences for interpreting European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 scores in patients with head and neck cancer.
    Head Neck. 2020 Jul 6. doi: 10.1002/hed.26363.
    PubMed         Abstract available
    
    

    
    Histopathology

33. JIANG D, Chen L, Huang J, Wang H, et al
    Mouse Double Minute 2 Amplification in Esophageal Squamous Cell Carcinoma Associated with Better Outcome.
    Histopathology. 2020 Jul 11. doi: 10.1111/his.14208.
    PubMed         Abstract available
    
    

    
    HNO

34. ROCH C, Schendzielorz P, Scherzad A, van Oorschot B, et al
    [Needs and burdens of palliative care patients with advanced and/or metastatic head and neck tumors].
    HNO. 2020;68:510-516.
    PubMed         Abstract available
    
    
35. HOFFMANN TK
    [ORATOR study : Surgery or radiotherapy for oropharyngeal carcinoma in the context of HPV?]
    HNO. 2020;68:278-279.
    PubMed        
    
    
36. LABBE D
    [Palliative care in otorhinolaryngology].
    HNO. 2020;68:475-482.
    PubMed         Abstract available
    
    

    
    Hum Pathol

37. THOMPSON LDR, Lewis JS Jr, Skalova A, Bishop JA, et al
    Don't stop the champions of research now: a brief history of head and neck pathology developments.
    Hum Pathol. 2020;95:1-23.
    PubMed         Abstract available
    
    

    
    Int J Cancer

38. CHEN W, Li H, Ren J, Zheng R, et al
    Selection of high-risk individuals for esophageal cancer screening: A prediction model of esophageal squamous cell carcinoma based on a multicenter screening cohort in rural China.
    Int J Cancer. 2020 Jul 14. doi: 10.1002/ijc.33208.
    PubMed         Abstract available
    
    

    
    Int J Pediatr Otorhinolaryngol

39. HASNAOUI M, Lahmar R, Ben Mabrouk A, Masmoudi M, et al
    Predictive epidemiological and clinical factors of nasopharyngeal carcinoma diagnosis: Adult versus pediatric population.
    Int J Pediatr Otorhinolaryngol. 2020;137:110203.
    PubMed         Abstract available
    
    

    
    Laryngoscope

40. THAKUR K, Singh CA, Thakar A, Kakkar A, et al
    Prevalence of Synchronous ESCN in Head and Neck Cancer: A Single-Institution Perspective.
    Laryngoscope. 2020 Jul 3. doi: 10.1002/lary.28821.
    PubMed         Abstract available
    
    

    
    Oral Oncol

41. KATSOULAKIS E, Yu Y, Apte AP, Leeman JE, et al
    Radiomic analysis identifies tumor subtypes associated with distinct molecular and microenvironmental factors in head and neck squamous cell carcinoma.
    Oral Oncol. 2020;110:104877.
    PubMed         Abstract available
    
    
42. TRIBIUS S, Pazdyka H, Tennstedt P, Busch CJ, et al
    Prognostic factors for lymphedema in patients with locally advanced head and neck cancer after combined radio(chemo)therapy- results of a longitudinal study.
    Oral Oncol. 2020;109:104856.
    PubMed         Abstract available
    
    
43. OSAZUWA-PETERS N, Barnes JM, Megwalu U, Adjei Boakye E, et al
    State Medicaid expansion status, insurance coverage and stage at diagnosis in head and neck cancer patients.
    Oral Oncol. 2020;110:104870.
    PubMed         Abstract available
    
    
44. LI X, Lee A, Cohen MA, Sherman EJ, et al
    Past, present and future of proton therapy for head and neck cancer.
    Oral Oncol. 2020;110:104879.
    PubMed         Abstract available
    
    
45. HUNG TM, Fan KH, Kang CJ, Huang SF, et al
    Lymph node-to-primary tumor standardized uptake value ratio on PET predicts distant metastasis in nasopharyngeal carcinoma.
    Oral Oncol. 2020;110:104756.
    PubMed         Abstract available
    
    
46. MATOS LL, Pinheiro RA, Kowalski LP
    Depth of invasion applied to oropharynx does not improve prognosis discrimination according to AJCC stage groups for oral cancer.
    Oral Oncol. 2020 Jul 9:104890. doi: 10.1016/j.oraloncology.2020.104890.
    PubMed        
    
    
47. BRINKMAN D, Callanan D, O'Shea R, Jawad H, et al
    Impact of 3 mm margin on risk of recurrence and survival in oral cancer.
    Oral Oncol. 2020;110:104883.
    PubMed         Abstract available
    
    
48. CHEN G, Wu Q, Jiang H, Zhong Y, et al
    The impact of the COVID-19 pandemic on head and neck cancer patients.
    Oral Oncol. 2020 Jul 2:104881. doi: 10.1016/j.oraloncology.2020.104881.
    PubMed        
    
    
49. SCHORN L, Lommen J, Sproll C, Kruskemper G, et al
    Evaluation of patient specific care needs during treatment for head and neck cancer.
    Oral Oncol. 2020;110:104898.
    PubMed         Abstract available
    
    

    
    Otolaryngol Head Neck Surg

50. REDDY PD, Yan F, Nguyen SA, Nathan CO, et al
    Factors Influencing the Development of Pneumonia in Patients With Head and Neck Cancer: A Meta-analysis.
    Otolaryngol Head Neck Surg. 2020 Jul 14:194599820938011.
    PubMed         Abstract available
    
    
51. STRAUGHAN AJ, Zapanta PE, Goodman JF
    Building Community Relations and Promoting Cancer Prevention: An Oral Cancer Screening Event.
    Otolaryngol Head Neck Surg. 2020 Jul 14:194599820942464.
    PubMed         Abstract available
    
    
52. TRIANTAFILLOU V, Rajasekaran K
    A Commentary on the Challenges of Telemedicine for Head and Neck Oncologic Patients during COVID-19.
    Otolaryngol Head Neck Surg. 2020;163:81-82.
    PubMed         Abstract available
    
    
53. CROSBY DL, Sharma A
    Evidence-Based Guidelines for Management of Head and Neck Mucosal Malignancies during the COVID-19 Pandemic.
    Otolaryngol Head Neck Surg. 2020;163:16-24.
    PubMed         Abstract available
    
    
54. RALLI M, Minni A, Candelori F, Cialente F, et al
    Effects of COVID-19 Pandemic on Otolaryngology Surgery in Italy: The Experience of Our University Hospital.
    Otolaryngol Head Neck Surg. 2020;163:86-88.
    PubMed         Abstract available
    
    

    
    PLoS One

55. JUNG HK, Tae CH, Lee HA, Lee H, et al
    Treatment pattern and overall survival in esophageal cancer during a 13-year period: A nationwide cohort study of 6,354 Korean patients.
    PLoS One. 2020;15:e0231456.
    PubMed         Abstract available
    
    
56. YOSHIDA R, Nagata M, Hirosue A, Kawahara K, et al
    Efficacy of adjuvant chemotherapy with S-1 in stage II oral squamous cell carcinoma patients: A comparative study using the propensity score matching method.
    PLoS One. 2020;15:e0231656.
    PubMed         Abstract available
    
    
57. ZHANG J, Zhang X, Meng Y, Chen Y, et al
    Contrast-enhanced ultrasound for the differential diagnosis of thyroid nodules: An updated meta-analysis with comprehensive heterogeneity analysis.
    PLoS One. 2020;15:e0231775.
    PubMed         Abstract available
    
    
58. BHALLA S, Kaur H, Kaur R, Sharma S, et al
    Expression based biomarkers and models to classify early and late-stage samples of Papillary Thyroid Carcinoma.
    PLoS One. 2020;15:e0231629.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

59. LIYANARACHCHI S, Gudmundsson J, Ferkingstad E, He H, et al
    Assessing thyroid cancer risk using polygenic risk scores.
    Proc Natl Acad Sci U S A. 2020;117:5997-6002.
    PubMed         Abstract available
    
    
60. FONG LY, Taccioli C, Palamarchuk A, Tagliazucchi GM, et al
    Abrogation of esophageal carcinoma development in miR-31 knockout rats.
    Proc Natl Acad Sci U S A. 2020;117:6075-6085.
    PubMed         Abstract available
    
    

    
    Radiother Oncol

61. PENG Y, Chen S, Qin A, Chen M, et al
    Magnetic resonance-based synthetic computed tomography images generated using generative adversarial networks for nasopharyngeal carcinoma radiotherapy treatment planning.
    Radiother Oncol. 2020 Jul 2. pii: S0167-8140(20)30385.
    PubMed         Abstract available
    
    
62. ZHONG LZ, Fang XL, Dong D, Peng H, et al
    A deep learning MR-based radiomic nomogram may predict survival for nasopharyngeal carcinoma patients with stage T3N1M0.
    Radiother Oncol. 2020 Jul 4. pii: S0167-8140(20)30387.
    PubMed         Abstract available
    
    
63. TCHELEBI LT, Goodman K
    Response to, "Role of neoadjuvant radiochemotherapy for esophageal cancers over pre/peri-operative chemotherapy in the era of COVID-19 and beyond".
    Radiother Oncol. 2020 Jul 13. pii: S0167-8140(20)30404.
    PubMed        
    
    
64. CELLINI F, Antonietta Gambacorta M, Carlo Mattiucci G, Valentini V, et al
    Role of neoadjuvant radiochemotherapy for esophageal cancers over pre/peri-operative chemotherapy in the era of COVID-19 and beyond.
    Radiother Oncol. 2020 Jul 13. pii: S0167-8140(20)30398.
    PubMed        
    
    
65. HONG RIM C
    Letter to the editor regarding the article "Selection of a high-level physician may help improve outcomes of nasopharyngeal carcinoma" by Fei et al.
    Radiother Oncol. 2020 Jul 13. pii: S0167-8140(20)30413.
    PubMed        
    
    

    
    Surgery

66. KWON JH, Yi JW
    Correlation between telomerase reverse transcriptase messenger RNA expression and survival of patients with papillary thyroid carcinoma.
    Surgery. 2020 Jul 5. pii: S0039-6060(20)30266-X. doi: 10.1016/j.surg.2020.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Head and Neck Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: